HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mutations in phospholipase C epsilon 1 are not sufficient to cause diffuse mesangial sclerosis.

Abstract
Diffuse mesangial sclerosis occurs as an isolated abnormality or as a part of a syndrome. Recently, mutations in phospholipase C epsilon 1 (PLCE1) were found to cause a nonsyndromic, autosomal recessive form of this disease. Here we describe three children from one consanguineous kindred of Pakistani origin with diffuse mesangial sclerosis who presented with congenital or infantile nephrotic syndrome. Homozygous mutations in PLCE1 (also known as KIAA1516, PLCE, or NPHS3) were identified following genome-wide mapping of single-nucleotide polymorphisms. All affected children were homozygous for a four-basepair deletion in exon 3, which created a premature translational stop codon. Analysis of the asymptomatic father of two of the children revealed that he was also homozygous for the same mutation. We conclude this nonpenetrance may be due to compensatory mutations at a second locus and that mutation within PLCE1 is not always sufficient to cause diffuse mesangial sclerosis.
AuthorsRodney D Gilbert, Claire L S Turner, Jane Gibson, Paul S Bass, Mushfequr R Haq, Esta Cross, David J Bunyan, Andrew R Collins, William J Tapper, Juliet C Needell, Beverley Dell, Newton E Morton, I Karen Temple, David O Robinson
JournalKidney international (Kidney Int) Vol. 75 Issue 4 Pg. 415-9 (Feb 2009) ISSN: 1523-1755 [Electronic] United States
PMID19037252 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Phosphoinositide Phospholipase C
  • phospholipase C epsilon
Topics
  • Family Health
  • Glomerular Mesangium (pathology)
  • Homozygote
  • Humans
  • Mutation
  • Pakistan
  • Pedigree
  • Penetrance
  • Phosphoinositide Phospholipase C (genetics)
  • Sclerosis (congenital, etiology, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: